Milbank LLP represented Morgan Stanley, Goldman Sachs and Mizuho as arrangers and Morgan Stanley as administrative agent, in providing senior secured financing to support a major investment and recapitalization of Precision Medicine Group (“PMG”) by affiliates of The Blackstone Group Inc. (“Blackstone”) (NYSE:BX).
Headquartered in Maryland with offices throughout North America and Europe, PMG is a specialized services company supporting next generation approaches to drug development and commercialization and a leading provider of mission-critical services that help biopharmaceutical and life sciences companies conduct clinical trials and bring novel therapies to market by integrating deep therapeutic knowledge, data and analytics, and human expertise.
The Global Leveraged Finance team was led by partners Marcus Dougherty and Benjamin Sayagh, with associates Benjamin Eisenstein and George K. Miller. Also providing advice on various points in the transaction were Tax partner Eschi Rahimi-Laridjani and associate Corey Spector and Intellectual Property associate Monica Arnold.
